Drugs: break in supply by class in France 2015-2016

Published by Statista Research Department, Jun 3, 2016
This statistic represents the percentage of drugs declared out of supply in France from February 2015 to May 2016, depending on the class of drugs. During the observed period of time, more than 5 percent of dermatological drugs were subject to a declaration of rupture because they were not dispensable within 72 hours.

Percentage of medicines (CIP code) reported as out of supply in France from February 2015 to May 2016, by drug class*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

June 2016

Region

France

Survey time period

February 2015 - May 2016

Supplementary notes

* Code CIP = code identifier of presentation, means according to the National Agency for the safety of the drug (ANSM) a single presentation defined by its denomination, its pharmaceutical form, its dosage, its packaging and the contents of its packaging.
Out of supply: impossibility for a city or hospital pharmacy to dispense a medicine to a patient within 72 hours.

The source adds the following information: "Calculated indicators for the declarations created from February 1, 2015. Consolidated figures for 318 operating laboratories. Products missing for at least 72 hours for at least 5% of pharmacies reporting to a subscriber laboratory (-> pharmacies connected to DP-Ruptures via their business software). "

Open this statistic in...
French
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Vaccine hesitancy in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Vaccine hesitancy in the U.S.

Global overview

8

Vaccine-preventable disease cases and vaccination rates

8

Hesitancy and exemptions

6

Injury and death from vaccinations

3

Public opinion

8

COVID-19 vaccine hesitancy

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.